SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OXHP: a premier value healthcare stock, check Value Line! -- Ignore unavailable to you. Want to Upgrade?

To: John A. Stoops who wrote (7)10/27/1997 9:07:00 AM
From: paru  Respond to of 29
 
Oxford health pre-announced a loss and stock is trading at 40 on instinet. I just heard it on cnbc.



To: John A. Stoops who wrote (7)10/27/1997 11:18:00 AM
From: jbe  Read Replies (1) | Respond to of 29
 
Unfortunately, I was right (post #6): when OXHP's free cash flow turned sharply negative, that was a harbinger of worse things to come. My instinct was to sell, but I was essentially too lazy to do it. Now OXHP has proved even more vulnerable than I thought, and I am more than $6,000 out of pocket on that stock alone today.

My advise to anyone who will take it: NEVER hold stocks in companies with negative cash flow. SELL them.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News